UC Davis Cancer Center researchers have received $19.1 million in funding from the National Cancer Institute and National Institutes of Health for drug trials and discovery.
David Gandara, professor of hematology and oncology, received an $8.6 million Early Cancer Therapeutics award from the NCI. Only eight such awards were granted. The awards fund early phase clinical trials of compounds that have shown great promise in the laboratory. Gandara's award will support clinical research carried out through the UC Davis Cancer Center-based California Cancer Consortium, which combines the clinical research resources of UC Davis, City of Hope in Duarte, Calif., the University of Southern California and the University of Pittsburgh.
Four grants totaling $10.5 million were awarded to Kit Lam, professor and chief of hematology and oncology: